PubRank

Daniel J Cook

Author PubWeight™ 30.53‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant 2004 2.35
2 De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years. Am J Transplant 2004 2.17
3 Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs. Transplantation 2007 1.80
4 Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome. J Am Coll Cardiol 2002 1.47
5 Computerized scoring of histopathology for predicting coronary vasculopathy, validated by intravascular ultrasound. J Heart Lung Transplant 2002 1.41
6 The impact of hypogammaglobulinemia on infection outcome in patients undergoing ventricular assist device implantation. J Heart Lung Transplant 2006 1.40
7 Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine. Transplantation 2002 1.26
8 Peritransplant ischemic injury is associated with up-regulation of stromal cell-derived factor-1. J Am Coll Cardiol 2005 0.99
9 Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation. J Heart Lung Transplant 2004 0.92
10 Transplant vasculopathy is associated with increased AlloMap gene expression score. J Heart Lung Transplant 2007 0.91
11 HLA sensitization in ventricular assist device recipients: does type of device make a difference? J Thorac Cardiovasc Surg 2004 0.90
12 Laparoscopic donor nephrectomy gene expression profiling reveals upregulation of stress and ischemia associated genes compared to control kidneys. Transplantation 2005 0.86
13 Biomechanics of Posterior Dynamic Fusion Systems in the Lumbar Spine: Implications for Stabilization With Improved Arthrodesis. Clin Spine Surg 2016 0.84
14 The effect of combined Angiotensin-converting enzyme inhibition and calcium antagonism on allograft coronary vasculopathy validated by intravascular ultrasound. J Heart Lung Transplant 2005 0.82
15 The effect of 2-gram versus 1-gram concentration controlled mycophenolate mofetil on renal transplant outcomes using sirolimus-based calcineurin inhibitor drug-free immunosuppression. Transplantation 2005 0.82
16 Increased expression of angiotensin II type 1 receptor (AGTR1) in heart transplant recipients with recurrent rejection. J Heart Lung Transplant 2006 0.82
17 Does acute cellular rejection correlate with cardiac allograft vasculopathy? J Heart Lung Transplant 2004 0.81
18 Quilty lesions are associated with increased expression of vitronectin receptor (alphavbeta3) and subsequent development of coronary vasculopathy. J Heart Lung Transplant 2003 0.80
19 The impact of donor gender on cardiac peri-transplantation ischemia injury. J Heart Lung Transplant 2005 0.80
20 Systemic up-regulation of angiotensin II type 1 receptor in cardiac donors with spontaneous intracerebral hemorrhage. Am J Transplant 2004 0.80
21 Characterization of articulation of the lumbar facets in the human cadaveric spine using a facet-based coordinate system. Spine J 2011 0.80
22 Ventricular assist devices and aggressive immunosuppression: looking beyond overall survival. J Heart Lung Transplant 2006 0.80
23 Angiotensin II receptors from peritransplantation through first-year post-transplantation and the risk of transplant coronary artery disease. J Am Coll Cardiol 2004 0.79
24 Cardiac angiotensin II receptors as predictors of transplant coronary artery disease following heart transplantation. Eur Heart J 2004 0.77
25 Donor or recipient hepatitis B seropositivity is associated with allograft vasculopathy. J Heart Lung Transplant 2006 0.77
26 A comparative analysis between survivors and nonsurvivors with antibody mediated cardiac allograft rejection. J Surg Res 2007 0.77
27 Donor spontaneous intracerebral hemorrhage is associated with systemic activation of matrix metalloproteinase-2 and matrix metalloproteinase-9 and subsequent development of coronary vasculopathy in the heart transplant recipient. Circulation 2003 0.77
28 Patterns of myocardial endothelin-1 expression and outcome after cardiac transplantation. Circulation 2002 0.76
29 Impact of donor spontaneous intracranial hemorrhage on outcome after heart transplantation. Am J Transplant 2004 0.76
30 Early and midterm risk of coronary allograft vasculopathy in patients bridged to orthotopic heart transplantation with ventricular assist devices. Transplantation 2005 0.76
31 The effect of two different cyclosporine formulations on the long-term progression to chronic rejection in renal allograft recipients. Clin Transplant 2002 0.75
32 Quantitative analysis of the nonlinear displacement-load behavior of the lumbar spine. J Biomech Eng 2014 0.75
33 Increased beta-myosin heavy chain in acute cellular rejection following human heart transplantation. Am J Transplant 2002 0.75
34 Systemic activation of integrin alphaVbeta3 in donors with spontaneous intracerebral hemorrhage is associated with subsequent development of vasculopathy in the heart transplant recipient. J Heart Lung Transplant 2005 0.75
35 Salvage of compromised renal vessels in kidney transplantation using third-party cadaveric extenders: impact on posttransplant anti-HLA antibody formation. Transplantation 2004 0.75